Mr. Nazmul Hasan, MP
President, Bangladesh Association of Pharmaceutical Industries
President, Bangladesh Cricket Board
Bangladesh Association of Pharmaceutical Industries (Bangladesh Aushad Shilpa Samity) feels pleasure to announce the 15th Asia Pharma Expo 2024 (APE 2024), an international exhibition on COMPLETE pharma manufacturing technologies focusing the South Asian pharmaceutical industries scheduled during February 29 to March 2, 2024 Bangabandhu Bangladesh-China, Friendship Exhibition Center (BBCFEC), Purbachal, Dhaka BANGLADESH
The Bangladesh pharma industry grew 12 to 15% last year and 1,500 medicines have been registered worldwide. We hope that drug exports would increase significantly in the coming years. In the current situation of LDC graduation period, Bangladesh pharma industry is offering medicines at very negligible cost bypassing the royalty fees. If the government gives registration of patented drugs before LDC graduation, the royalty fees can be escaped. The price of medicine hasn't gone up that much when compared to our production expenses. Besides, you cannot just hike up the prices of medicine as we have to take into consideration people's purchasing power. So we all have to work together to provide quality medicines at low prices in such difficult times. Sri Lanka and Pakistan are suffering from a shortage of drugs. Bangladesh is in a much better situation than them. By working together, we will be able to overcome this difficult situation. Despite the tough times, the pharma industry grew by 12 to 15% last year. We are trying to ensure that there is no shortage in the supply of medicines
In brief: Bangladesh pharma manufacturing industry:
The pharmaceutical sector of Bangladesh is progressing multifold. Apart from meeting the domestic demands of pharma formulations, the pharma industry is also earning huge foreign exchange from the exports. With the existing market value of about USD 3 billion, the Bangladesh pharma manufacturing industry is rapidly marching ahead with great potential as 98% of the country’s total demand for medicine is being met by nearly 300 domestic manufacturers, which is a milestone in the history of the Bangladesh pharmaceutical industry. At the same time, these local manufacturers are exporting as well to more than 142 countries across the world.
The anticipated market size of the Bangladesh pharmaceutical industry is more than USD 6 billion by 2025 with an absolute growth of 114% from 2019 levels, while the pharma exports of Bangladesh is likely to cross USD 450 Million by 2025. The share of the local manufacturing companies is above 90%.
An encouraging development is more than 47 units at API Manufacturing Park are coming up near Dhaka. The Bangladesh pharma industry now meets around 98% of the local demand for medicines, which is a milestone in the history of the pharmaceutical industry.
